Circular to Licensed Corporations in relation to the reporting of OTC derivatives transactions to the HKMA trade repository – Training and testing schedule for the second half of 2017

24 Aug 2017

We refer to the Circular issued on 27 January 2017 regarding the training and testing schedules of the Hong Kong Monetary Authority (HKMA)’s trade repository (HKTR) for the first half of 2017.

The HKMA has announced today a new round of training and simulation tests to be conducted in the second half of 2017, which will cover the reporting of transactions in all 5 major asset classes of OTC derivatives products under phase 2 reporting, as well as the reporting of valuation information. Phase 2 reporting requirements came into effect on 1 July 2017.

Licensed Corporations that may be subject to mandatory reporting obligations must sign up for the HKTR’s reporting service and complete a scenario test and a product specific test (simulation test – part 1 and part 2) (including entities which intend to report via an agent) before they will be accepted by the HKTR for reporting.  Those who have already signed up and completed a scenario test under phase 1 mandatory reporting are also required to complete a product specific test (simulation test – part 2), in order to be accepted by the HKTR for reporting additional OTC derivatives products under phase 2 reporting.

Licensed Corporations must make sure that their reporting agents, if any, meet all technical requirements specified by the HKTR.  They must also test the trade submission process with their agents prior to reporting.

Attached to this Circular are the letter and enrolment forms for the training sessions and simulation tests issued by the HKMA.

Should you have any queries regarding the above, please contact the HKTR at (852) 8100 3115 or email to

Supervision of Markets Division
Securities and Futures Commission

Click here to download the document

Supplementary document:
Announcement from HKMA

Page last updated : 24 Aug 2017